Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZYLA LIFE SCIENCES

 SummaryNewsCompany 
Company
Zyla Life Sciences, formerly Egalet Corporation, is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company's products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company's product SPRIX Nasal Spray,... 
More about the company
All news about ZYLA LIFE SCIENCES
2020ZYLA LIFE SCIENCES : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
2020ZYLA LIFE SCIENCES : Termination of a Material Definitive Agreement, Completion of Acquisi..
AQ
2020Zyla Life Sciences Repaid All Outstanding Indebtedness and Terminated the Commitment Un..
CI
2020ZYLA LIFE SCIENCES : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020ZYLA LIFE SCIENCES : Results of Operations and Financial Condition, Other Events, Financia..
AQ
2020ZYLA LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
2020Zyla Life Sciences Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
2020ZYLA LIFE SCIENCES : to Host Conference Call and Webcast to Discuss First Quarter 2020 Fin..
PR
2020ZYLA LIFE SCIENCES : Assertio Therapeutics Announces its Virtual 2020 Annual Meeting on Ma..
AQ
2020ZYLA LIFE SCIENCES : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
2020ZYLA LIFE SCIENCES : Results of Operations and Financial Condition, Other Events, Financia..
AQ
2020ZYLA LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
2020Zyla Life Sciences Reports Earnings Results for the Full Year Ended December 31, 2019
CI
2020Zyla Life Sciences Auditor Raises 'Going Concern' Doubt
CI
2020ZYLA LIFE SCIENCES : to Host Conference Call and Webcast to Discuss Year End 2019 Financia..
PR
More news
News in other languages on ZYLA LIFE SCIENCES

- No features available -

More news
Managers and Directors
Todd N. Smith President, Chief Executive Officer & Director
Daniel A. Peisert CFO, Secretary, Treasurer & Director
Jean-Francois B. Formela Independent Director
Matthew Pauls Independent Director
E. Blair Clark-Schoeb Senior Vice President-Communications
Sector and Competitors
1st jan.Capi. (M$)
ZYLA LIFE SCIENCES-18.00%20
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431